Adjuvant radiotherapy after salvage lymph node dissection because of nodal relapse of prostate cancer versus salvage lymph node dissection only [Adjuvante Strahlentherapie nach Salvage-Lymphadenektomie beim nodalen Prostatakarzinomrezidiv im Vergleich zur alleinigen Salvage-Lymphadenektomie]

被引:0
|
作者
Rischke H.C. [1 ,2 ]
Schultze-Seemann W. [5 ]
Wieser G. [2 ]
Krönig M. [5 ]
Drendel V. [4 ]
Stegmaier P. [1 ]
Krauss T. [3 ]
Henne K. [1 ]
Volegova-Neher N. [1 ]
Schlager D. [5 ]
Kirste S. [3 ]
Grosu A.-L. [1 ]
Jilg C.A. [5 ]
机构
[1] Department of Radiation Oncology, University of Freiburg, Freiburg
[2] Department of Nuclear Medicine, University of Freiburg, Freiburg
[3] Department of Radiology, University of Freiburg, Freiburg
[4] Department of Pathology, University of Freiburg, Freiburg
[5] Department of Urology, University of Freiburg, Hugstetterstr. 55, Freiburg
关键词
Adjuvant radiotherapy; Lymph node metastases; Prostate cancer relapse; Salvage lymph node dissection; Salvage radiotherapy;
D O I
10.1007/s00066-014-0763-5
中图分类号
学科分类号
摘要
Background: Nodal pelvic/retroperitoneal recurrent prostate cancer (PCa) after primary therapy can be treated with salvage lymph node dissection (salvage-LND) in order to delay disease progression and offer cure for a subset of patients. Whether adjuvant radiotherapy (ART) in affected regions improves the outcome by elimination of residual tumour burden remains unclear. Methods: A total of 93 patients with exclusively nodal PCa relapse underwent choline-positron-emission tomography-computed-tomography-directed pelvic/retroperitoneal salvage-LND; 46 patients had surgery only and 47 patients received ART in regions with proven lymph node metastases. In case of subsequent prostate specific antigen (PSA) progression, different imaging modalities were performed to confirm next relapse within or outside the treated region (TR). Mean follow-up was 3.2 years. Results: Lymphatic tumour burden was balanced between the two groups. Additional ART resulted in delayed relapse within TR (5-year relapse-free rate 70.7 %) versus surgery only (5-year relapse-free rate 26.3 %, p < 0.0001). In both treatment arms, time to next relapse outside the TR was almost equal (median 27 months versus 29.6 months, p = 0.359). With respect to the detection of the first new lesion, regardless if present within or outside the TR, 5 years after the treatment 34.3 % of patients in the group with additional ART were free of relapse, versus 15.4 % in the surgery only group (p = 0.0122). ART had no influence on the extent of PSA reduction at latest follow-up compared to treatment with surgery only. Conclusion: ART after salvage-LND provides stable local control in TR and results in overall significant improved next-relapse-free survival, compared to patients who received surgery only in case of nodal PCa-relapse. © 2014, Springer-Verlag Berlin Heidelberg.
引用
收藏
页码:310 / 320
页数:10
相关论文
共 50 条
  • [11] Salvage Lymph Node Dissection for Node-only Recurrence of Prostate Cancer: Ready for Prime Time?
    Suardi, Nazareno
    Briganti, Alberto
    Gandaglia, Giorgio
    Fossati, Nicola
    Montorsi, Francesco
    [J]. EUROPEAN UROLOGY, 2017, 71 (05) : 693 - 694
  • [12] ROBOTIC SALVAGE RETROPERITONEAL AND PELVIC LYMPH NODE DISSECTION FOR "NODE-ONLY" RECURRENT PROSTATE CANCER
    Fay, Carlos
    Abreu, Andre
    Park, Daniel
    Rajarubendra, Niero
    Freitas, Daniel Melecchi
    Cacciamani, Giovanni
    Gill, Inderbir
    [J]. JOURNAL OF UROLOGY, 2017, 197 (04): : E910 - E910
  • [13] Salvage lymph node dissection in nodal oligorecurrent prostate cancer: literature review and our experience
    Shirokorad, V. I.
    Izmailov, A. A.
    Lupashko, D. G.
    [J]. ONKOUROLOGIYA, 2024, 20 (01): : 52 - 59
  • [14] Adjuvant radiotherapy after salvage surgery for melanoma recurrence in a node field following a previous lymph node dissection
    Holtkamp, Lodewijka H. J.
    Lo, Serigne N.
    Thompson, John F.
    Spillane, Andrew J.
    Stretch, Jonathan R.
    Saw, Robyn P. M.
    Shannon, Kerwin F.
    Nieweg, Omgo E.
    Hong, Angela M.
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2023, 128 (01) : 97 - 104
  • [15] Toxicity and quality of life after choline-PET/CT directed salvage lymph node dissection and adjuvant radiotherapy in nodal recurrent prostate cancer
    Jilg, Cordula A.
    Leifert, Anja
    Schnell, Daniel
    Kirste, Simon
    Volegova-Neher, Natalia
    Schlager, Daniel
    Wieser, Gesche
    Henne, Karl
    Schultze-Seemann, Wolfgang
    Grosu, Anca-L
    Rischke, Hans Christian
    [J]. RADIATION ONCOLOGY, 2014, 9 : 1 - 4
  • [16] Toxicity and quality of life after choline-PET/CT directed salvage lymph node dissection and adjuvant radiotherapy in nodal recurrent prostate cancer
    Cordula A Jilg
    Anja Leifert
    Daniel Schnell
    Simon Kirste
    Natalia Volegova-Neher
    Daniel Schlager
    Gesche Wieser
    Karl Henne
    Wolfgang Schultze-Seemann
    Anca-L Grosu
    Hans Christian Rischke
    [J]. Radiation Oncology, 9
  • [17] REPEAT SALVAGE LYMPH NODE DISSECTION FOR RECURRENCE OF PROSTATE CANCER USING PSMA-RADIOGUIDANCE SURGERY (RGS) AFTER PRIOR SALVAGE LYMPH NODE DISSECTION WITH OR WITHOUT INITIAL RGS-SUPPORT
    Falkenbach, Fabian
    Knipper, Sophie
    Koehler, Daniel
    Steuber, Thomas
    Graefen, Markus
    Budaeus, Lars
    Maurer, Tobias
    [J]. JOURNAL OF UROLOGY, 2023, 209 : E947 - E947
  • [18] De novo neurogenic bladder dysfunction after salvage lymph node dissection in patients with nodal recurrence of prostate cancer
    Hanske, Julian
    Mueller, Guido
    van Ophoven, Arndt
    von Landenberg, Nicolas
    Roghmann, Florian
    Palisaar, Rein-Jueri
    von Bodman, Christian
    Noldus, Joachim
    Brock, Marko
    [J]. NEUROUROLOGY AND URODYNAMICS, 2018, 37 (06) : 1988 - 1995
  • [19] DE NOVO NEUROGENIC BLADDER DYSFUNCTION AFTER SALVAGE LYMPH NODE DISSECTION IN PATIENTS WITH NODAL RECURRENCE OF PROSTATE CANCER
    Hanske, Julian
    Mueller, Guido
    van Ophoven, Arndt
    von Landenberg, Nicolas
    Roghmann, Florian
    Palisaar, Rein-Jueri
    von Bodman, Christian
    Noldus, Joachim
    Brock, Marko
    [J]. JOURNAL OF UROLOGY, 2018, 199 (04): : E1187 - E1187
  • [20] Safety and efficiency of repeat salvage lymph node dissection for recurrence of prostate cancer using PSMA-radioguided surgery (RGS) after prior salvage lymph node dissection with or without initial RGS support
    Fabian Falkenbach
    Sophie Knipper
    Daniel Koehler
    Francesca Ambrosini
    Thomas Steuber
    Markus Graefen
    Lars Budäus
    Matthias Eiber
    Lukas Lunger
    Flemming Lischewski
    Matthias M. Heck
    Tobias Maurer
    [J]. World Journal of Urology, 2023, 41 : 2343 - 2350